Detailed information for compound 314392

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 362.468 | Formula: C22H26N4O
  • H donors: 3 H acceptors: 1 LogP: 2.92 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Nc1ccc(cc1)C(=O)NCCN1CCC(CC1)c1cccc2c1cc[nH]2
  • InChi: 1S/C22H26N4O/c23-18-6-4-17(5-7-18)22(27)25-12-15-26-13-9-16(10-14-26)19-2-1-3-21-20(19)8-11-24-21/h1-8,11,16,24H,9-10,12-15,23H2,(H,25,27)
  • InChiKey: NONLEPSJHYRPDC-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens adrenoceptor alpha 1A Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis CMGC family protein kinase 0.0043 0 0.5
Echinococcus granulosus fatty acid amide hydrolase 1 0.0107 0.1246 1
Loa Loa (eye worm) hypothetical protein 0.0058 0.0286 0.2296
Loa Loa (eye worm) hypothetical protein 0.0107 0.1246 1
Mycobacterium leprae PROBABLE METHYLTRANSFERASE 0.0058 0.0286 0.5
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0107 0.1246 1
Entamoeba histolytica protein kinase domain containing protein 0.0043 0 0.5
Trypanosoma cruzi glycogen synthase kinase 3, putative 0.0043 0 0.5
Echinococcus granulosus fatty acid amide hydrolase 1 0.0107 0.1246 1
Schistosoma mansoni o-methyltransferase 0.0058 0.0286 0.2296
Schistosoma mansoni amidase 0.0107 0.1246 1
Schistosoma mansoni o-methyltransferase 0.0058 0.0286 0.2296
Trypanosoma brucei protein kinase, putative 0.0043 0 0.5
Brugia malayi O-methyltransferase 0.0058 0.0286 0.2296
Leishmania major glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 0.0043 0 0.5
Brugia malayi amidase 0.0107 0.1246 1
Giardia lamblia Kinase, CMGC GSK 0.0043 0 0.5
Schistosoma mansoni o-methyltransferase 0.0058 0.0286 0.2296
Entamoeba histolytica protein kinase domain containing protein 0.0043 0 0.5
Schistosoma mansoni fatty-acid amide hydrolase 0.0107 0.1246 1
Onchocerca volvulus 0.0058 0.0286 1
Trichomonas vaginalis CMGC family protein kinase 0.0043 0 0.5
Schistosoma mansoni o-methyltransferase 0.0058 0.0286 0.2296
Giardia lamblia Kinase, CMGC GSK 0.0043 0 0.5
Loa Loa (eye worm) O-methyltransferase 0.0058 0.0286 0.2296
Entamoeba histolytica protein kinase, putative 0.0043 0 0.5
Wolbachia endosymbiont of Brugia malayi O-methyltransferase 0.0058 0.0286 0.5
Brugia malayi O-methyltransferase family protein 0.0058 0.0286 0.2296
Mycobacterium tuberculosis Probable catechol-O-methyltransferase 0.05 0.8875 1
Brugia malayi O-methyltransferase family protein 0.0058 0.0286 0.2296
Brugia malayi O-methyltransferase family protein 0.0058 0.0286 0.2296
Plasmodium vivax glycogen synthase kinase 3, putative 0.0043 0 0.5
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0107 0.1246 1
Plasmodium falciparum glycogen synthase kinase 3 0.0043 0 0.5
Onchocerca volvulus 0.0058 0.0286 1
Toxoplasma gondii cell-cycle-associated protein kinase GSK, putative 0.0043 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 9.5 nM Binding affinity was determined towards bovine Alpha-1A adrenergic receptor ChEMBL. 15715476
Ki (binding) = 9.5 nM Binding affinity was determined towards bovine Alpha-1A adrenergic receptor ChEMBL. 15715476

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.